Follitropin alfa versus lutropin alfa (37.5 IU/day) versus lutropin alfa (75 IU/day) in infertile women of advanced reproductive age

Trial Profile

Follitropin alfa versus lutropin alfa (37.5 IU/day) versus lutropin alfa (75 IU/day) in infertile women of advanced reproductive age

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Sep 2011

At a glance

  • Drugs Follitropin alfa (Primary) ; Lutropin alfa (Primary) ; Triptorelin (Primary)
  • Indications Infertility
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Sep 2011 New trial record
    • 01 Sep 2011 Primary endpoint 'Clinical-pregnancy-rate' has not been met.
    • 01 Sep 2011 Results published in the European Journal of Obstetrics and Gynecology and Reproductive Biology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top